The Vancouver-based company aims to develop cosmetics and drugs that treat skin diseases such as atopic dermatitis, acne, psoriasis, rosacea, and skin cancer, as well as promoting wound healing and balancing the microbiome. Their proprietary natural compound has antimicrobial, anti-inflammatory, antitumor, and anti-oxidizing properties, making it a promising treatment for various skin conditions. Derm-Biome focuses on advancing safe and effective topical therapies for inflammatory skin diseases and skin cancer, which are significant unmet clinical needs.